FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Olympia Compounding Pharmacy dba Olympia Pharmacy Re-2 Recall

RE-2, Papaverine 30 mg/mL

Olympia Compounding Pharmacy dba Olympia Pharmacy · Orlando, FL

Risk level
Class II
Reported by FDA
May 4, 2022
Recall ID
D-0814-2022
Check your lot numberHow we source this data

Summary

Olympia Compounding Pharmacy dba Olympia Pharmacy recalled Re-2 starting Apr 4, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0814-2022 on May 4, 2022. Reason: CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated. Status: Terminated.

Why it was recalled

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Product description

RE-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0016-10.

Lot numbers, UPCs & expiration codes

Lots: E42G11 BUD: 5/11/2022, H41003 BUD: 8/3/2022; H41B03 BUD: 8/3/2022

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0814-2022
Classification
Class II
Status
Terminated
Recall initiated
Apr 4, 2022
FDA report date
May 4, 2022
Quantity
2201 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy

Original FDA data

Every field from FDA enforcement report D-0814-2022, exactly as published.

Show all FDA fields
City
Orlando
State
FL
Status
Terminated
Country
United States
Event ID
89938
Address
6700 Conroy Rd Ste 155
Code information
Lots: E42G11 BUD: 5/11/2022, H41003 BUD: 8/3/2022; H41B03 BUD: 8/3/2022
Postal code
32835-3515
Report date
May 4, 2022
Product type
Drugs
Recall number
D-0814-2022
Classification
Class II
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
Product quantity
2201 vials
Termination date
Jun 17, 2024
Reason for recall
CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Voluntary / mandated
Voluntary: Firm initiated
Product description
RE-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0016-10.
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Apr 4, 2022
Initial firm notification
Letter
Center classification date
Apr 27, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0814-2022, published May 4, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls